Lidocaine 01
Lidocaine Ointment
Product Images NDC 0168-0204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 0168-0204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fougera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lidocaine 03
This is a description of a lidocaine ointment with a 5% concentrated USP in a tube with a tamper-resistant cap. It is indicated not to be used in the eyes and has a net weight of 35.44 g (1 oz). The product should be stored at a controlled room temperature of 15° to 30°C (59° to 86°F) and be kept out of reach of children. However, there is no information about the usage, indications, or contraindications of the product.*
Lidocaine02
This is a product description for Lidocaine Ointment, which is resistant to high temperatures. It contains 5% Lidocaine base in a water-soluble base consisting of polyethylene glycol 300 and polyethylene glycol 1450. The package insert provides full prescribing information and usual dosage. The ointment should not be used in the eyes, and it should be stored at a controlled room temperature of 15°C to 30°C. The product should be kept out of reach of children. Directions for opening and closing the tube are provided, along with the Control No. and expiration date. The product is made by E. Fougera & Co., a division of Fougera Pharmaceuticals Inc., in Melville, New York.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
